An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United StatesLynn R. Webster, Wayne Wakeland, Richard L. Stieg et al.|Pain Medicine|2011Cited by 295
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painLynn R. Webster, Eric Carter, Jan Peter Jansen et al.|Pain|2008Cited by 144
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic painJohn F. Peppin, Vanhove, Lynn R. Webster et al.|Journal of Pain Research|2011Cited by 50
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic painLynn R. Webster, Geertrui F. Vanhove, John F. Peppin et al.|Diabetes Research and Clinical Practice|2011Cited by 44
Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic painLynn R. Webster, Vanhove, John F. Peppin et al.|Journal of Pain Research|2012Cited by 29